Gladstone Institutional Advisory LLC Has $639,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Gladstone Institutional Advisory LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,391 shares of the financial services provider’s stock after selling 977 shares during the period. Gladstone Institutional Advisory LLC’s holdings in iShares Biotechnology ETF were worth $639,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter worth $30,000. Bbjs Financial Advisors LLC bought a new stake in iShares Biotechnology ETF in the 2nd quarter valued at about $31,000. Voisard Asset Management Group Inc. bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at $59,000. Chris Bulman Inc bought a new stake in iShares Biotechnology ETF during the second quarter worth $64,000. Finally, Eastern Bank bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $65,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of IBB stock opened at $142.78 on Monday. iShares Biotechnology ETF has a 52 week low of $113.56 and a 52 week high of $150.57. The firm’s 50-day simple moving average is $145.02 and its two-hundred day simple moving average is $140.46.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.